Sean Cunliffe

Guest Contributor
December 6, 2013

Sean Cunliffe has been appointed CEO of Sitka Biopharma Inc, a spinoff of CDRD Ventures Inc (see brief on this page). Cunliffe is a pharmaceutical sales and marketing executive with more than 30 years of experience working in big pharma. At Sitka he will work with founding scientists Dr Helen Burt and Dr Don Brooks (Univ of British Columbia) and Dr Martin Gleave (Vancouver Prostate Centre) to advance the firm's polymer technology platform for the treatment of bladder cancer to commercial viability. Prior to joining Sitka, Cunliffe held senior roles with Angiotech Pharmaceutical and Neuromed Pharmaceuticals (now Zalicus Inc, Cambridge MA). He also held several positions at Wyeth Pharmaceuticals and, Glaxo Wellcome. Cunliffe holds a BSc in biology from Queen's Univ and an MBA in finance from McMaster Univ….


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.